메뉴 건너뛰기





Volumn 68, Issue 2, 2009, Pages 296-

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biological: results from a 24-week multicentre randomised placedo-controlled trial (Annals of the Rheumatic Diseases (2008) 67 (1516-23))

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 58849108578     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: None     Document Type: Erratum
Times cited : (10)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.